Equity

12 Months Ended

Dec. 31, 2016

Equity [Abstract]

Equity

Note 11. Equity

a. Share capital

The Company’s issued share capital is composed of ordinary shares at NIS 0.01 par value. Ordinary shares confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends if declared.

As of December 31, 2016, and 2015, there were 52,639 thousands ordinary shares and 52,082 thousands ordinary shares issued and outstanding, respectively. The Company’s ordinary shares are traded in the United States on the Nasdaq Global Select Market under the ticker symbol “SSYS”.

For significant share issuance in connection with business combinations during the years ended December 31, 2016, 2015 and 2014, refer to note 2.

b. Stock-based compensation plans

The Stratasys Ltd. 2012 Omnibus Equity Incentive Plan (the “2012 Plan”), which became effective upon closing of the Stratasys-Objet merger, provides for the grant of options, restricted shares, restricted share units (“RSUs”) and other share-based awards to the Company’s and its subsidiaries’ respective directors, employees, officers, consultants, and advisors and to any other person whose services are considered valuable to the Company or any of its affiliates. Under the 2012 plan, options and RSUs generally have a contractual term of ten years from the grant date. Options granted become exercisable and RSUs are vested over the vesting period, which is normally a four-year period beginning on the grant date, subject to the employee’s continuing service to the Company. As of December 31, 2016, 3.0 million shares were available for equity awards under the 2012 plan. On January 1, 2017, the reserve pool under the 2012 plan was automatically increased by 0.5 million shares.

Stock options

A summary of the stock option activity for the year ended December 31, 2016 is as follows:

			Weighted Average
	Number of Options		Exercise Price
Options outstanding as of December 31, 2015	2,449,742		$	39.73
Granted	559,340			23.03
Exercised	(119,564	)		9.91
Forfeited	(274,057	)		42.74
Options outstanding as of December 31, 2016	2,615,461		$	37.21
Options exercisable as of December 31, 2016	1,426,304		$	38.63

The following table summarizes information about stock options outstanding at December 31, 2016:

					Options Outstanding						Options Exercisable
					Outstanding		Weighted- Average				Exercisable
					options at		Remaining		Weighted- Average		options at		Weighted- Average
Range of					December 31,		Contractual		Exercise		December 31,		Exercise
Exercise Prices					2016		Life in Years		Price		2016		Price
$	2.21	-	$	22.16		666,353		2.21	$	11.03	$	604,717	$	10.04
	23.41	-		25.50		663,895		6.17		23.93		100,661		25.10
	29.37	-		45.00		654,586		7.29		34.99		247,231		35.14
$	46.87	-	$	120.51		630,627		4.19		81.16		473,695		79.82
						2,615,461	$	4.96	$	37.21		1,426,304	$	38.63
	Aggregate intrinsic
	value (U.S. $ in
	thousands)				$	4,100					$	4,082

As of December 31, 2016, the weighted-average remaining contractual life of exercisable options was 3.6 years. The total intrinsic value of options exercised during 2016, 2015 and 2014 was approximately $1.5 million, $4.6 million and $55.6 million, respectively.

The Company used the Black-Scholes option-pricing model to determine the fair value of options granted during 2016, 2015 and 2014. The following assumptions were applied in determining the options’ fair value on their grant date:

	2016		2015		2014
Risk-free interest rate	1.1%-1.5%		1.6% - 1.9%		1.3% - 2.0%
Expected option term (years)	5.2-6.0		6.0		4.2 - 6.5
Expected share price volatility	53.6%-56.1%		50.1%-53.5%		45.8% - 47.6%
Dividend yield		-		-		-
Weighted average grant date fair value	$	12.36	$	15.49	$	60.82

As of December 31, 2016, the Company had 1.2 million unvested options. As of December 31, 2016, the unrecognized compensation cost related to all unvested, equity-classified stock options of $13.0 million is expected to be recognized as an expense on a straight-line basis over a weighted-average period of 2.5 years.

Restricted Stock Units

A summary of the Company’s RSUs activity for the year ended December 31, 2016 is as follows:

			Weighted Average
			Grant Date Fair
	Number of RSUs		Value
Unvested RSUs outstanding as of December 31, 2015	559,124		$	81.35
Vested	(184,621	)		94.36
Forfeited	(106,747	)		81.90
Unvested RSUs outstanding as of December 31, 2016	267,756		$	72.17

The total vesting-date value of equity classified RSUs vested during 2016 was $3.5 million. As of December 31, 2016, the unrecognized compensation cost related to all unvested equity classified RSUs of $11.5 million is expected to be recognized as an expense on a straight-line basis over a weighted-average period of 1.9 years.

Stock-based compensation expense for stock options and equity classified RSUs included in the Company’s Statements of Operations were allocated as follows:

	2016		2015		2014
	(U.S. $ in thousands)
Cost of sales	$	2,780	$	5,381	$	4,493
Research and development, net		4,768		5,759		4,862
Selling, general and administrative		13,225		18,870		20,852
Total stock-based compensation expenses	$	20,773	$	30,010	$	30,207

c. Accumulated other comprehensive loss

The following tables present the changes in the components of accumulated other comprehensive loss, net of taxes for the years ended December 31, 2016, 2015 and 2014:

	Year ended December 31, 2016
	Net unrealized gain			Foreign currency
	(loss) on cash flow			translation
	hedges			adjustments			Total
				U.S. $ in thousands
Balance as of January 1, 2016	$	(107	)	$	(10,667	)	$	(10,774	)
Other comprehensive loss before
reclassifications		523			(2,788	)		(2,265	)
Amounts reclassified from accumulated
other comprehensive loss		(440	)		-			(440	)
Other comprehensive income (loss)		83			(2,788	)		(2,705	)
Balance as of December 31, 2016	$	(24	)	$	(13,455	)	$	(13,479	)

	Year ended December 31, 2015
	Net unrealized gain			Foreign currency
	(loss) on cash flow			translation
	hedges			adjustments			Total
				U.S. $ in thousands
Balance as of January 1, 2015	$	(1,243	)	$	(2,404	)	$	(3,647	)
Other comprehensive loss before
reclassifications		(288	)		(8,263	)	$	(8,551	)
Amounts reclassified from accumulated
other comprehensive loss		1,424			-		$	1,424
Other comprehensive income (loss)		1,136			(8,263	)		(7,127	)
Balance as of December 31, 2015	$	(107	)	$	(10,667	)	$	(10,774	)

	Year ended December 31, 2014
	Net unrealized gain			Foreign currency
	(loss) on cash flow			translation
	hedges			adjustments			Other			Total
	(U.S. $ in thousands)
Balance as of January 1, 2014	$	153		$	1,922		$	(167	)	$	1,908
Other comprehensive income before
reclassifications		(2,222	)		(4,326	)		—			(6,548	)
Amounts reclassified from accumulated
other comprehensive income		826			—			167			993
Other comprehensive income (loss)		(1,396	)		(4,326	)		167			(5,555	)
Balance as of December 31, 2014	$	(1,243	)	$	(2,404	)	$	—		$	(3,647	)

Realized gains and losses on cash flow hedges were reclassified primarily to research and development, net and selling and general and administrative expenses. Other reclassifications from accumulated other comprehensive loss were reclassified to financial expense, net.